Institutional investors purchased a net $1.2 million shares of OREX during the quarter ended December 2015 and now own 69.65% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE BAUPOST GROUP LLC Bought 20.0 Million shares of Orexigen Therapeutics Inc